1.
Saslow D,
Boetes C,
Burke W,
et al.
(2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
CA Cancer J Clin 57:75–89.
2.
Kuhl CK,
Schrading S,
Bieling HB,
et al.
(2007) MRI for diagnosis of pure ductal carcinoma in situ: A prospective observational study.
Lancet 370:485–492.
3.
Morrow M,
Waters J,
Morris E (2011) MRI for breast cancer screening,
diagnosis,
and treatment.
Lancet 378:1804–1811.
4.
Bluemke DA,
Gatsonis CA,
Chen MH,
et al.
(2004) MR imaging prior to breast biopsy: Results of the International Breast Magnetic Resonance Consortium (IBMC) trial.
JAMA 292:2735–2742.
5.
Harms SE,
Flamig DP,
Hesley KL,
et al.
(1993) MR imaging of the breast with rotating delivery of excitation off resonance: Clinical experience with pathologic correlation.
Radiology 187:493–501.
6.
Orel SG,
Schnall MD (2001) MR imaging of the breast for the detection,
diagnosis,
and staging of breast cancer.
Radiology 220:13–30.
7.Sardanelli F,
Podo F,
Santoro F,
et al.
(2011) Multicenter surveillance of women at high genetic breast cancer risk using mammography,
ultrasonography,
and contrast-enhanced magnetic resonance imaging (the High Breast Cancer Risk Italian 1 study): Final results.
Invest Radiol 46:94–105.
8.
Moy L,
Elias K,
Patel V,
et al.
(2009) Is breast MRI helpful in the evaluation of inconclusive mammographic findings? AJR Am J Roentgenol 193:986–993.
9.
Pinker K,
Grabner G,
Bogner W,
et al.
(2009) A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: Initial results.
Invest Radiol 44:553–558.
10.
Lehman CD,
Gatsonis C,
Kuhl CK,
et al.
(2007) MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer.
N Engl J Med 356:1295–1303.
11.
Kuhl C,
Weigel S,
Schrading S,
et al.
(2010) Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: The EVA trial.
J Clin Oncol 28:1450–1457.
12.
Passaperuma K,
Warner E,
Causer PA,
et al.
(2012) Long-term results of screening with magnetic resonance imaging in women with BRCA mutations.
Br J Cancer 107:24–30.
13.
Warner E,
Hill K,
Causer P,
et al.
(2011) Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.
J Clin Oncol 29:1664–1669.
14.
Kuhl CK, Schrading S, Strobel K, et al.
(2014) Abbreviated breast magnetic resonance imaging (MRI): First postcontrast subtracted images and maximum-intensity projection—A novel approach to breast cancer screening with MRI. J Clin Oncol 32:2304–2310
15.
DeMartini W,
Lehman C.
A review of current evidence-based clinical applications for breast magnetic resonance imaging.
Top Magn Reson Imaging 2008;19:143–150.
16.
Berg WA,
Gutierrez L,
NessAiver MS,
et al.
Diagnostic accuracy of mammography,
clinical examination,
US,
and MR imaging in preoperative assessment of breast cancer.
Radiology 2004;233:830–849
17.
Sinha S,
Sinha U (2002) Functional magnetic resonance of human breast tumors: diffusion and perfusion imaging.
Ann N Y Acad Sci 980: 95–115
18.
Wu D,
Li G,
Zhang J,
Chang S,
Hu J,
Dai Y (2014) Characterization of breast tumors using diffusion kurtosis imaging (DKI) PLoS ONE 18;9(11):e113240
19.
Elizabeth A.
Morris (2014) Rethinking Breast Cancer Screening: Ultra FAST Breast Magnetic Resonance Imaging. J Clin Oncol 32:2281-2283
20.
Kun S, Xiaosong C, Weimin C, Xiaochun F, Caixia F, Xu Y, Ying Z,
Kemin C,
Kunwei S, Fuhua Y (2015) Breast Cancer: Diffusion Kurtosis MR Imaging-Diagnostic Accuracy and Correlation with Clinical-Pathologic Factors.
RSNA 4:141625